Reaktion #157339

ord-0931d4773abb4a2daff5b525401691b0

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Einengenthe reaction mixture was concentrated under reduced pressure
  2. 2
    Sonstigepurified by HPLC (5 to 50% MeCN/0.1% TFA in H2O/0.1% TFA gradient)
  3. 3
    workup.ADDITIONThe fractions containing the desired product
  4. 4
    Extraktionwere extracted with EtOAc (3×)
  5. 5
    TrocknenThe combined organics were dried over Na2SO4
  6. 6
    Filtrationfiltered
  7. 7
    Einengenconcentrated under reduced pressure
  8. 8
    workup.DISSOLUTIONThe material was dissolved in MeOH (1 mL)
  9. 9
    EinengenThe mixture was concentrated under reduced pressure

Vorschrift

4 M HCl in 1,4-dioxane (6 mL, 24 mmol) was added to a solution of tert-butyl 4-(2-methylbenzo[d]thiazol-5-ylcarbamoyl)-3-((pyridin-3-yloxy)methyl)piperazine-1-carboxylate di-TFA salt (129.9 mg, 0.183 mmol) in MeOH (1 mL). After 1 h, the reaction mixture was concentrated under reduced pressure and purified by HPLC (5 to 50% MeCN/0.1% TFA in H2O/0.1% TFA gradient). The fractions containing the desired product were combined and brought to pH 12 with 1 N NaOH and were extracted with EtOAc (3×). The combined organics were dried over Na2SO4, filtered, and concentrated under reduced pressure. The material was dissolved in MeOH (1 mL) and 4 M HCl in 1,4-dioxane (1 equiv. HCl, 0.028 mL) was added. The mixture was concentrated under reduced pressure to give 44.6 mg (58%) of the title compound as the hydrochloride salt. LC-MS: RT=4.22 min, [M+H]+=384.1.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08822472B2uspto-grants-2014_09